Chronic Bacterial Prostatitis: Clinical Trials

4 trials for Chronic Bacterial Prostatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1
Phase 41Completed 1

Follow Chronic Bacterial Prostatitis: new trials by email Literature Review of Chronic Bacterial Prostatitis trials Research Report on Chronic Bacterial Prostatitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Role of Butirprost® in Combination With Antibiotics in Chronic Bacterial Prostatitis (CBP) Treatment
Sodium Hyaluronate, Levofloxacin 500mg - Prostate Inflammation, Prostate Disease
Phase 3CompletedFederico II University602024-03-012024-11-18
Prulifloxacin in Chronic Bacterial Prostatitis (CBP)
Prulifloxacin 600 mg, Levofloxacin 500mg - Chronic Bacterial Prostatitis
Phase 2CompletedAziende Chimiche Riunite Angelini Francesco S.p.A1682016-02-022021-05-13
Treatment of Chronic Bacterial Prostatitis
Third generation fluoroquinolone, Nutritional supplement + third generation fluoroquinolone - Chronic Bacterial Prostatitis
Phase 4CompletedUniversity of Roma La Sapienza2102012-01-012014-05-05
Diagnostic Challenges in IC (and Male CPPS)
Genomic and proteomic biomarker discovery - Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Chronic Bacterial Prostatitis
CompletedBeth Israel Deaconess Medical Center10002003-09-012020-08-04

Narrower conditions

Prostatitis (4)  ·  Cystitis, Interstitial (1)  ·  Prostatic Diseases (1)

Broader conditions

Genital Diseases (4)  ·  Genital Diseases, Male (4)  ·  Male Urogenital Diseases (4)  ·  Urogenital Diseases (4)  ·  Prostatic Diseases (3)  ·  Cystitis (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Urinary Bladder Diseases (1)  ·  Urologic Diseases (1)

Interventions

Levofloxacin (2)  ·  Dietary Supplements (1)  ·  Genome (1)  ·  Hyaluronic Acid (1)  ·  prulifloxacin (1)

Sponsors

Aziende Chimiche Riunite Angelini Francesco S.p.A (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Federico II University (1)  ·  University of Roma La Sapienza (1)

Countries

Italy (3)  ·  Greece (1)  ·  United States (1)

Top investigators

Ettore De Berardinis, Professor (1)  ·  Jordan D Dimitrakoff, MD, PhD (1)

Results publications

PMID 18308097, PMID 25038794

NIH funding

2014 (1), R01DK065990 (1)